Vor Biopharma reprices 6.76M underwater stock options to $1.34 per share

Vor Biopharma Inc.

Board reduces exercise price to $1.34 for options with original prices from $1.36 to $44.96.
Repricing applies to continuing employees; CEO's 2.13M options repriced (avg $4.30).
Options may not be exercised at reduced price before February 3, 2026 retention end.
CSO Tirtha Chakraborty and CMO Eyal Attar also have options repriced.
Move intended to retain and motivate employees without additional equity or cash.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.